Novel Health Strategies team analyzed marketing, pricing, access and launch strategies for all products approved in 2011-2012 to develop a report on top strategy mishaps.
The goal of this report is to provide industry executives with an analysis of mistakes made by manufacturers for launching recent products and develop lessons and implications for 2013-2020.
This report was developed by Novel Health Strategies team in partnership with key opinion leaders and market access stakeholders.
The following topics are discussed in the report:
What were the top mistakes made by manufacturers for products launched in 2011-2012?
What factors led to the failure of products, previously deemed as potential blockbusters?
How did KOLs and payer stakeholders react to manufacturer's strategies?
What lessons can be learned from these product failures for future products?
What market access and evidence generation strategies can be developed for future products?
The report is complementary and can be requested for in-person presentation by emailing at